Renk's €7.4bn Backlog Raises the Stakes: Can the Order Machine Finally Deliver Margin?

Renk's record €1.195bn orders and €7.4bn backlog contrast with a 44% share drop. Can the defence firm convert backlog into profit?

The disconnect is hard to ignore. Renk Group's order intake hit a record €1.195bn in the first half of 2026, its backlog swelled to an all-time high of €7.4bn, and yet the share price remains a shadow of its former self. At Friday's close of €50.77, the stock sits roughly 44% below its 52-week peak of €90.20 — a gap that raises an uncomfortable question for investors: is the market simply refusing to believe the numbers, or is it pricing in something the headline figures don't capture?

The latest half-year results, published on Thursday, certainly paint a picture of a company firing on all cylinders operationally. Second-quarter orders alone reached €612.8m, the highest single-quarter volume the Augsburg-based defence specialist has ever recorded, contributing to a 29.7% year-on-year jump in order intake. The book-to-bill ratio climbed to 1.9x from 1.5x in the prior-year period — for every euro of revenue, Renk is pulling in nearly two euros of new business. Revenue growth, however, was far more modest at 2.7%, reaching €637.2m, underscoring the lag between order wins and actual revenue recognition.

That lag is precisely where the market's scepticism takes root. Management reaffirmed its 2026 guidance of more than €1.5bn in revenue and adjusted EBIT between €255m and €285m, but the reported first-half EBIT was weighed down by consulting costs tied to the pending acquisition of David Brown Defence. The adjusted group margin did improve by 120 basis points year-on-year, yet the question of whether the record backlog can be converted into sustainable profitability remains the central test for the coming months.

A technical hurdle with symbolic weight

The share's recent recovery — up 9.99% over the past 30 days and more than a quarter off its 52-week low of €40.41 — has brought it to a critical juncture. The 200-day moving average sits at €53.01, a level that has acted as a ceiling for weeks. With the stock now just over 4% below that line, the next move could be decisive. A breakout would signal that the longer-term downtrend has finally broken; another rejection would likely reignite doubts about the sustainability of the rebound.

The stock remains 20.81% lower over the past twelve months and down 5.89% year-to-date, a performance that stands in stark contrast to the operational momentum. JPMorgan reaffirmed its "Overweight" rating on Thursday, joining DZ Bank and Deutsche Bank Research in maintaining bullish stances after the half-year numbers. Yet the chart tells a more cautious story, and the gap between analyst enthusiasm and price action has become the defining feature of Renk's market narrative.

What's priced in — and what isn't

The technical picture is only part of the equation. With annualised volatility of roughly 41%, Renk remains a stock that demands a strong stomach. The RSI reading of 64.6 suggests the recent rally has already absorbed a meaningful portion of the good news, leaving limited room for error in the near term.

The July refinancing — a €1.05bn package comprising a syndicated loan, revolving facility and guarantee line with a five-year tenor plus extension options — was significantly oversubscribed, a signal that the banking consortium retains confidence in the company's capital market standing. The David Brown Defence acquisition, agreed at between $200m and $250m, brings with it a backlog and pipeline exceeding £700m for 2026 through 2030. But the deal is not yet closed: completion is expected in the fourth quarter of 2026, pending regulatory approvals, leaving integration risk and the question of whether acquisition costs will prove genuinely one-off unresolved.

A disclosure from BlackRock on Tuesday added another layer of ambiguity: after crossing a threshold on 29 July, the asset manager now holds 4.07% of voting rights, with shifts between direct holdings and financial instruments suggesting repositioning rather than a clear directional signal.

The conversion question

For bulls, the structural demand dynamics are compelling. The record order book, the oversubscribed refinancing and the strategic logic of the David Brown Defence acquisition all point to a company well positioned in a persistently strong defence procurement environment. The 120-basis-point margin improvement, if sustained into the second half, would lend credibility to the full-year guidance.

For bears, the counter-arguments are equally clear. The modest revenue growth relative to the order surge shows just how long the pipeline between booking and billing can be. The stock's continued failure to reclaim its 200-day average, despite the recent bounce, suggests the overarching trend has yet to turn. And with the David Brown integration still ahead, the risk of further one-off charges cannot be dismissed.

The immediate test is technical: whether the €50 level holds and whether the 200-day line at €53.01 finally gives way. The more consequential test, however, comes later — the fourth-quarter completion of the David Brown Defence acquisition, followed by the full-year 2026 results that will determine whether Renk's adjusted EBIT guidance of €255m to €285m was ambition or arithmetic. The order book has already answered the question of demand. Whether it can answer the question of profit is still very much open.